Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 29 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

0%

0 of 22 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
26(89.7%)
Phase 1
2(6.9%)
Phase 3
1(3.4%)
29Total
N/A(26)
Phase 1(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (29)

Showing 20 of 29 trials
NCT07349420Phase 1Completed

EF-M2 (Immutalon) Multiple Ascending Dose Study in Moderate-to-Severe Rheumatoid Arthritis

Role: lead

NCT06877364Phase 1Completed

Safety, Tolerability and Efficacy of GcMAF in Patients With Chronic Inflammatory Diseases

Role: lead

NCT06863948Not ApplicableCompleted

Integrative Group Psychotherapy (Terebenin's Method) in Adults With Subclinical and Mild/Moderate Anxiety and Depression

Role: lead

NCT06877377Not ApplicableNot Yet Recruiting

Study of the Safety and Efficacy of Natural Genome Reconstruction Technology of Hematopoietic Stem Cells in Adult Patients

Role: lead

NCT06434077Phase 3Not Yet Recruiting

Clinical Trial Protocol: Randomized Placebo-Controlled Pilot Study of GcMAF (Soloways TM) in Patients With Metastatic Breast Cancer

Role: lead

NCT06264570Not ApplicableRecruiting

Evaluation of a Genetically Determined Personalized Approach in Prescribing Biologically Active Substances in Patients With Elevated Blood Homocysteine Levels.

Role: lead

NCT06264544Not ApplicableNot Yet Recruiting

Trial to Evaluate the Efficacy of a Zinc, Selenium, and L-Tyrosine Supplement in the Prevention of Thyrotoxicosis in Subjects With r25191G/A SEPP1 Polymorphism

Role: lead

NCT06269406Not ApplicableNot Yet Recruiting

A Combination of Ibuprofen With Curcumin Covered With Liquorice Root Supplementation in the Management of Postoperative Dental Pain in Adults

Role: lead

NCT06914921Not ApplicableCompleted

Enteric-Coated Peppermint Oil Versus Standard Antispasmodic in SLC6A4 (5-HTTLPR) Carriers With Irritable Bowel Syndrome.

Role: lead

NCT06914934Not ApplicableCompleted

Study of High-Dose Resveratrol in Patients With Stable Ischemic Heart Disease

Role: lead

NCT06911983Not ApplicableNot Yet Recruiting

Comparative Efficacy of Metformin and Berberine Among TCF7L2 (rs7903146) TT vs. CC Genotype Carriers With Type 2 Diabetes

Role: lead

NCT06867913Not ApplicableCompleted

A Study of Selenomethionine and Myo-inositol(SOLOWAYS_TM) in Patients With Autoimmune Thyroiditis Carrying the DIO2 Thr92Ala Polymorphism

Role: lead

NCT06470399Not ApplicableCompleted

AI-Guided (GenAIS TM) Versus Standard Physician-Guided Dietary Supplementation for Managing Metabolic Syndrome

Role: lead

NCT06867939Not ApplicableCompleted

A Study of Curcumin (Soloways ™) in Patients With Inflammatory Bowel Disease Homozygous for the IL-10 Variant

Role: lead

NCT06470412Not ApplicableCompleted

Personalized Management of Autoimmune Diseases With AI-Guided (GenAIS TM) Dietary Supplementation

Role: lead

NCT06470425Not ApplicableCompleted

Optimizing Mental Health Management With AI-Guided (GenAIS TM) Dietary Supplementation

Role: lead

NCT06163443Not ApplicableCompleted

Evaluating the Impact of B Vitamin Supplementation (Soloways™) on Homocysteine and LDL-C Levels in Patients With MTHFR, MTR, and MTRR Polymorphisms.

Role: lead

NCT06188832Not ApplicableCompleted

Efficacy of Dietary Fiber Supplementation (Soloways) in Patients With Specific Genetic Polymorphisms

Role: lead

NCT06313164Not ApplicableCompleted

The Impact of Oral Glutathione on Oxidative Damage and Glycated Hemoglobin (HbA1c) Levels in Type 2 Diabetes Patients

Role: lead

NCT06154408Not ApplicableCompleted

Evaluating the Impact of Omega-3 Fatty Acid Supplementation (Soloways™) on Lipid Profiles in Adults With PPARG Polymorphisms

Role: lead